Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28

J Neurol Sci. 2016 Mar 15;362:287-91. doi: 10.1016/j.jns.2016.02.007. Epub 2016 Feb 4.

Abstract

Mutations in DDHD1 cause the SPG28 subtype of hereditary spastic paraplegia (HSP). Recent studies suggested that mitochondrial dysfunction occurs in SPG28. Here we describe two siblings with SPG28, and report evidence of mitochondrial impairment in skeletal muscle and skin fibroblasts. Patient 1 (Pt1) was a 35-year-old man with spastic paraparesis and urinary incontinence, while his 25-year-old brother (Pt2) had gait spasticity and motor axonal neuropathy. In these patients we identified the novel homozygous c.1429C>T/p.R477* mutation in DDHD1, using a next-generation sequencing (NGS) approach. Histochemical analyses in muscle showed mitochondrial alterations, and multiple mitochondrial DNA (mtDNA) deletions were evident. In Pt1, respiratory chain enzyme activities were altered in skeletal muscle, mitochondrial ATP levels reduced, and analysis of skin fibroblasts revealed mitochondrial fragmentation. It seems possible that the novel nonsense mutation identified abolishes DDHD1 protein function thus altering oxidative metabolism. Qualitative alterations of mtDNA could have a pathogenetic significance. We suggest to perform DDHD1 analysis in patients with multiple mtDNA deletions.

Keywords: DDHD1; Hereditary spastic paraplegia; Mitochondrial disease; SPG28.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Adult
  • DNA Mutational Analysis
  • Humans
  • Male
  • Mitochondrial Diseases / etiology*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Phospholipases A2, Calcium-Independent / genetics*
  • Phospholipases A2, Calcium-Independent / metabolism
  • Siblings
  • Spastic Paraplegia, Hereditary / complications*
  • Spastic Paraplegia, Hereditary / genetics*

Substances

  • Adenosine Triphosphate
  • Phospholipases A2, Calcium-Independent